IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content (Q64449144)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

Elisabeth Sanders

4

object named as

Elisabeth A M Sanders

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Lotte H Hendrikx

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Guy A M Berbers

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Reinier H Veenhoven

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Anne-Marie Buisman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

0 references

publication date

1 September 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

47

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

6530-6536

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Effects of Pertussis Vaccination on Disease: Vaccine Efficacy in Reducing Clinical Severity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

The seroepidemiology of Bordetella pertussis infection in Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Resurgence of pertussis in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Large-scale comparative analysis of pertussis population dynamics: periodicity, synchrony, and impact of vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Recent developments in pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Pertussis sources of infection and routes of transmission in the vaccination era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Pertussis in adults: frequency of transmission after household exposure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Measuring immunoglobulin g antibodies to tetanus toxin, diphtheria toxin, and pertussis toxin with single-antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Booster vaccination of toddlers with reduced antigen content diphtheria -- tetanus -- acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inacti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Improving the cellular pertussis vaccine: increased potency and consistency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Human B cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Crucial role of antibodies to pertactin in Bordetella pertussis immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Vaccines: correlates of vaccine-induced immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.052

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.08.052

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19729085%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64449144&oldid=1402058691"